Ling Pamela M, Kim Minji, Egbe Catherine O, Patanavanich Roengrudee, Pinho Mariana, Hendlin Yogi
Department of Medicine and Center for Tobacco Control Research and Education, University of California San Francisco, San Francisco, California, USA
Department of Health Promotion, Education, and Behavior, University of South Carolina Arnold School of Public Health, Columbia, South Carolina, USA.
Tob Control. 2022 Mar;31(2):222-228. doi: 10.1136/tobaccocontrol-2021-056552.
Tobacco, nicotine and related products have and continue to change rapidly, creating new challenges for policies regulating their advertising, promotion, sponsorship and sales. This paper reviews recent commercial product offerings and the regulatory challenges associated with them. This includes electronic nicotine delivery systems, electronic non-nicotine delivery systems, personal vaporisers, heated tobacco products, nicotine salts, tobacco-free nicotine products, other nicotine products resembling nicotine replacement therapies, and various vitamin and cannabis products that share delivery devices or marketing channels with tobacco products. There is substantial variation in the availability of these tobacco, nicotine, vaporised, and related products globally, and policies regulating these products also vary substantially between countries. Many of these products avoid regulation by exploiting loopholes in the definition of tobacco or nicotine products, or by occupying a regulatory grey area where authority is unclear. These challenges will increase as the tobacco industry continues to diversify its product portfolio, and weaponises 'tobacco harm reduction' rhetoric to undermine policies limiting marketing, promotion and taxation of tobacco, nicotine and related products. Tobacco control policy often lags behind the evolution of the industry, which may continue to sell these products for years while regulations are established, refined or enforced. Policies that anticipate commercial tobacco, nicotine and related product and marketing changes and that are broad enough to cover these product developments are needed.
烟草、尼古丁及相关产品一直在迅速变化,而且这种变化仍在持续,这给规范其广告、促销、赞助及销售的政策带来了新挑战。本文回顾了近期的商业产品供应情况以及与之相关的监管挑战。这包括电子尼古丁传送系统、电子无尼古丁传送系统、个人雾化器、加热烟草制品、尼古丁盐、无烟碱产品、其他类似尼古丁替代疗法的尼古丁产品,以及与烟草制品共用递送装置或营销渠道的各类维生素和大麻产品。这些烟草、尼古丁、雾化及相关产品在全球的可得性差异很大,各国对这些产品的监管政策也大不相同。其中许多产品通过利用烟草或尼古丁产品定义中的漏洞,或占据监管权限不明确的灰色地带,来规避监管。随着烟草行业继续使其产品组合多样化,并利用“烟草危害降低”的说辞来破坏限制烟草、尼古丁及相关产品营销、促销和征税的政策,这些挑战将会增加。烟草控制政策往往落后于行业发展,在制定、完善或执行相关法规的数年时间里,烟草行业可能会继续销售这些产品。因此,需要出台能够预见到商业烟草、尼古丁及相关产品和营销变化,且覆盖面足够广以涵盖这些产品发展的政策。